Inovio Pharmaceuticals, Inc. (INO) earnings
INO earnings moved a median of -0.71% by the close. Quarterly and annual INO reports and results, each read against the price at its own news timestamp. Back to the INO overview →
28 measured INO earnings events.
Where these INO earnings landedvs 28 measured INO earnings reactions
| Middle 50% of INO earnings reactions | -3.63% to +2.15% |
|---|---|
| Median reaction (to close) | -0.71% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 INO earnings events with a measured close landed between -3.63% and +2.15%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +3.46% | +11.12% | |
| INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Press release | +3.46% | +11.12% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +1.94% | +5.43% | |
| INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights | Press release | +1.94% | +5.43% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | +1.51% | -3.49% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -3.50% | +0.00% | |
| INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights | Press release | -3.50% | +0.00% | |
| INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 | Press release | +2.34% | -2.73% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +5.30% | +12.58% | |
| INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights | Press release | +5.30% | +12.58% | |
| INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025 | Press release | -0.68% | +0.00% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +2.59% | -2.08% | |
| INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | Press release | +2.59% | -2.08% | |
| INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 | Press release | -1.06% | +1.06% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -1.87% | -6.22% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -2.28% | -12.78% | |
| INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | -2.28% | -12.78% | |
| INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 | Press release | -0.17% | -1.39% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30 | SEC filing · Form 10-Q | +1.53% | -0.71% | |
| INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | +1.53% | -0.71% | |
| INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 | Press release | -0.37% | +0.28% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Mar 31 | SEC filing · Form 10-Q | +2.28% | -3.63% | |
| INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights | Press release | +2.28% | -3.63% | |
| INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 | Press release | +5.48% | +8.59% | |
| Form 10-K INOVIO PHARMACEUTICALS, For: Dec 31 | SEC filing · Form 10-K | -0.31% | -6.42% | |
| Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 10-Q | -6.00% | -6.24% | |
| INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights | Press release | -6.00% | -6.24% | |
| INOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023 | Press release | +0.00% | +0.65% |
Keep exploring
More INO: analyst actions → · SEC filings → · INO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OPHTHOTECH CORP COMMON (OPHT) | 660 | -0.20% | 43% |
| Gritstone bio, Inc. (GRTS) | 659 | -0.01% | 50% |
| VistaGen Therapeutics, Inc. (VTGN) | 658 | +0.16% | 52% |
| Quanterix Corporation (QTRX) | 657 | -0.21% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.